Ridinilazole

Published
Topics: New Medicines

dm+d

Unassigned

New Medicines

Clostridium difficile infection

Information

New molecular entity
Summit Therapeutics
Summit Therapeutics

Development and Regulatory status

Phase II Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Some other antibacterials (05.01.07)
Narrow spectrum antibacterial
A total of 13,177 cases of Clostridioides difficile infection were reported by NHS trusts in England between 1 April 2019 and 31 March 2020. This is a small increase of 7.4% from 2018/19 (n = 12,274), and a decrease of 76.3% from 2007/08 (n = 55,498).[14]
Clostridium difficile infection
Oral